EMBECTA CORP. Amortization of Debt Issuance Costs
EMBECTA CORP. (EMBC) reported Amortization of Debt Issuance Costs of $5.20 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-07
- EMBECTA CORP. amortization of debt issuance costs for the quarter ending 2026-06-30 was $1.40M, a 41.67% decline year-over-year.
- EMBECTA CORP. amortization of debt issuance costs for the quarter ending 2026-03-31 was $1.90M, a 5.00% decline year-over-year.
- EMBECTA CORP. amortization of debt issuance costs for the quarter ending 2025-12-31 was $1.90M, a 9.52% decline year-over-year.
- EMBECTA CORP. amortization of debt issuance costs for the quarter ending 2025-09-30 was $2.60M, a 23.81% increase year-over-year.
- EMBECTA CORP. amortization of debt issuance costs for fiscal 2025 was $9.10M, a 31.88% increase from fiscal 2024.
- EMBECTA CORP. amortization of debt issuance costs for fiscal 2024 was $6.90M, a 7.81% increase from fiscal 2023.
- EMBECTA CORP. amortization of debt issuance costs for fiscal 2023 was $6.40M, a 100.00% increase from fiscal 2022.
- EMBECTA CORP. amortization of debt issuance costs for fiscal 2022 was $3.20M.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $3.30M derived: sum of 2 quarters · filed 2026-08-07 | $5.20M 10-Q · filed 2026-08-07 | $7.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | $3.80M 10-Q · filed 2026-05-05 | $6.40M derived: sum of 3 quarters · filed 2026-05-05 | $8.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $1.90M 10-Q · filed 2026-02-05 | $4.50M derived: sum of 2 quarters · filed 2026-02-05 | $6.90M derived: sum of 3 quarters · filed 2026-08-07 | $8.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-09-30 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $5.00M derived: sum of 2 quarters · filed 2026-08-07 | $7.00M derived: sum of 3 quarters · filed 2026-08-07 | $9.10M 10-K · filed 2025-11-25 |
| 2025-06-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $4.40M derived: sum of 2 quarters · filed 2026-08-07 | $6.50M 10-Q · filed 2026-08-07 | $8.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | $4.10M 10-Q · filed 2026-05-05 | $6.20M derived: sum of 3 quarters · filed 2026-05-05 | $7.80M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $2.10M 10-Q · filed 2026-02-05 | $4.20M derived: sum of 2 quarters · filed 2026-02-05 | $5.80M derived: sum of 3 quarters · filed 2026-02-05 | $7.40M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-09-30 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $3.70M derived: sum of 2 quarters · filed 2025-11-25 | $5.30M derived: sum of 3 quarters · filed 2025-11-25 | $6.90M 10-K · filed 2025-11-25 |
| 2024-06-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | $3.20M derived: sum of 2 quarters · filed 2025-08-08 | $4.80M 10-Q · filed 2025-08-08 | $6.40M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-03-31 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-09 | $3.20M 10-Q · filed 2025-05-09 | $4.80M derived: sum of 3 quarters · filed 2025-11-25 | $6.40M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-12-31 | $1.60M 10-Q · filed 2025-02-06 | $3.20M derived: sum of 2 quarters · filed 2025-11-25 | $4.80M derived: sum of 3 quarters · filed 2025-11-25 | $6.40M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-09-30 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $3.20M derived: sum of 2 quarters · filed 2025-11-25 | $4.80M derived: sum of 3 quarters · filed 2025-11-25 | $6.40M 10-K · filed 2025-11-25 |
| 2023-06-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $3.20M derived: sum of 2 quarters · filed 2024-08-09 | $4.80M 10-Q · filed 2024-08-09 | $6.10M derived: sum of 4 quarters · filed 2024-12-11 |
| 2023-03-31 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | $3.20M 10-Q · filed 2024-05-09 | $4.50M derived: sum of 3 quarters · filed 2024-12-11 | $6.30M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-12-31 | $1.60M 10-Q · filed 2024-02-09 | $2.90M derived: sum of 2 quarters · filed 2024-12-11 | $4.70M derived: sum of 3 quarters · filed 2024-12-11 | $4.80M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-09-30 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-11 | $3.10M derived: sum of 2 quarters · filed 2024-12-11 | $3.20M derived: sum of 3 quarters · filed 2024-12-11 | $3.20M 10-K · filed 2024-12-11 |
| 2022-06-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $1.90M derived: sum of 2 quarters · filed 2023-08-08 | $1.90M 10-Q · filed 2023-08-08 | $1.90M derived: sum of 4 quarters · filed 2023-11-29 |
| 2022-03-31 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | $100.00K 10-Q · filed 2023-05-12 | $100.00K derived: sum of 3 quarters · filed 2023-11-29 | $100.00K derived: sum of 4 quarters · filed 2023-11-29 |
| 2021-12-31 | $0.00 10-Q · filed 2023-02-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-29 | $0.00 derived: sum of 3 quarters · filed 2023-11-29 | |
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | $0.00 derived: sum of 2 quarters · filed 2023-11-29 | $0.00 10-K · filed 2023-11-29 | |
| 2021-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-13 | |||
| 2020-09-30 | $0.00 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |